Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul 18;17(1):108.
doi: 10.1186/s12874-017-0393-6.

A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines

Pankaj Mistry  1 , Janet A Dunn  2 , Andrea Marshall  2
Affiliations
Review

A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines

Pankaj Mistry et al. BMC Med Res Methodol. .

Abstract

Background: The application of adaptive design methodology within a clinical trial setting is becoming increasingly popular. However the application of these methods within trials is not being reported as adaptive designs hence making it more difficult to capture the emerging use of these designs. Within this review, we aim to understand how adaptive design methodology is being reported, whether these methods are explicitly stated as an 'adaptive design' or if it has to be inferred and to identify whether these methods are applied prospectively or concurrently.

Methods: Three databases; Embase, Ovid and PubMed were chosen to conduct the literature search. The inclusion criteria for the review were phase II, phase III and phase II/III randomised controlled trials within the field of Oncology that published trial results in 2015. A variety of search terms related to adaptive designs were used.

Results: A total of 734 results were identified, after screening 54 were eligible. Adaptive designs were more commonly applied in phase III confirmatory trials. The majority of the papers performed an interim analysis, which included some sort of stopping criteria. Additionally only two papers explicitly stated the term 'adaptive design' and therefore for most of the papers, it had to be inferred that adaptive methods was applied. Sixty-five applications of adaptive design methods were applied, from which the most common method was an adaptation using group sequential methods.

Conclusions: This review indicated that the reporting of adaptive design methodology within clinical trials needs improving. The proposed extension to the current CONSORT 2010 guidelines could help capture adaptive design methods. Furthermore provide an essential aid to those involved with clinical trials.

Keywords: Adaptive; Adaptive design; Cancer; Clinical trials; Interim analysis; Review.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Modified PRIMSA flow diagram showing the review process
See this image and copyright information in PMC

References

    1. Chow S-C, Chang M. Adaptive design methods in clinical trials-a review. Orphanet J Rare Dis. 2008;3(11):169–190. - PMC - PubMed
    1. Kairalla JA, et al. Adaptive trial designs: a review of barriers and opportunities. Trials. 2012;13(1):145. doi: 10.1186/1745-6215-13-145. - DOI - PMC - PubMed
    1. Food US, Administration D. Adaptive design clinical trials for drugs and biologics. Biotechnol Law Rep. 2010;29(2):173. doi: 10.1089/blr.2010.9967. - DOI
    1. FDA, Guidance for Industry: Adaptive Design Clinical Trials for Drugs and Biologics, U.S.D.o.H.a.H. Services, Editor. 2010.
    1. CHMP, CHMP reflection paper on methodological issues in confirmatory clinical trials planned with an adaptive design, 2007. 2012.

MeSH terms

LinkOut - more resources